Search results
Lab to jab in 100 days: manufacturing flexibility for future rapid responses
Pharmaceutical Technology· 5 days agoThe Coalition for Epidemic Preparedness Innovations (CEPI) is on a mission to explore whether new...
Strategies to address the viral vector manufacturing shortage
Pharmaceutical Technology· 5 days agoWith the exciting promise of addressing previously unmet medical needs, the rapidly growing field of...
Valneva’s chikungunya vaccine gains EC’s market authorisation
Pharmaceutical Technology· 5 days agoThis collaboration is part of an agreement entered in July 2019, which includes funding of up to...
Maharashtra Challan Update: State Govt Plans To Link Traffic Violators' Bank Accounts To E-Challans
One India· 5 days agoThe Maharashtra government seeks central approval to link traffic violators' bank accounts to...
Women who run, climb, squat, twirl… for two fitness workouts for pregnant mothers
Mid Day· 6 days agoTelling women what they should and shouldn’t do is almost a national pastime. Last week everyone,...
The Hindu Morning Digest: June 30, 2024
The Hindu· 6 days agoThe long wait is over. India is world champion again .In a classic ICC Men’s T20 World Cup final sure to be remembered for years to come, India made...
A pandemic upon us: A superbug threat hides amid us in plain sight, but little is being done to...
Financial Express· 7 days agoUnlike computing, the-re’s no Moore’s Law in the world of antibiotics, and humanity is dangerously...
Endemic dengue may have helped stem severity of early COVID wave in India: study
The Hindu· 7 days agoCan the dengue virus beat the coronavirus and is it why the early wave of the pandemic in 2020...
A Quiet Place: Day One Isn’t Really About the Monsters at All
IGN India· 7 days agoWarning: Full spoilers follow for A Quiet Place: Day One. In his sequel, A Quiet Place Part II, we follow existing characters further into the future without doubling back to starting lines.